Hope Ayurvedic Medicines Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 19.56%
(FY 2020)
- Profit -37.11%
(FY 2020)
- Ebitda 22.02%
(FY 2020)
- Net Worth 2.34%
(FY 2020)
- Total Assets -4.31%
(FY 2020)
About Hope Ayurvedic Medicines
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rama Katkar and Asha Katkar serve as directors at the Company.
- CIN/LLPIN
U24233PN2006PTC129173
- Company No.
129173
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2006
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Hope Ayurvedic Medicines Private Limited offer?
Hope Ayurvedic Medicines Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Ayurvedic Herbal Syrups & Tonics, Herbal & Ayurvedic Medical Services, Ayurvedic Treatment, Nutraceuticals & Dietary Supplements, Nutraceuticals, Medical Surgery & Treatment Centres, Medical Treatment Services, Brain & Nervous System Drugs.
Who are the key members and board of directors at Hope Ayurvedic Medicines?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rama Katkar  | Director | 20-Oct-2006 | Current |
| Asha Katkar | Director | 20-Oct-2006 | Current |
Financial Performance of Hope Ayurvedic Medicines.
Hope Ayurvedic Medicines Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 19.56% increase. The company also saw a substantial fall in profitability, with a 37.11% decrease in profit. The company's net worth moved up by a moderate rise of 2.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hope Ayurvedic Medicines?
In 2020, Hope Ayurvedic Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hope Contractors Private LimitedActive 5 years 1 monthRama Katkar and Asha Katkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hope Ayurvedic Medicines?
Unlock and access historical data on people associated with Hope Ayurvedic Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hope Ayurvedic Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hope Ayurvedic Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
